expenditures in Sweden are due to its low public prices, rather than to low levels of consumption. Sweden introduced a new pricing … and reimbursement scheme in 2002. Its main features are the use of cost-effectiveness analysis for determining the … reimbursement status of new pharmaceuticals and mandatory substitution of the lowest-cost generic alternative. The use of cost …

This paper describes and assesses pharmaceutical pricing and reimbursement policies in Canada, considering them in the …

the value and subsequent reimbursement of new and existing drugs, as well as reforms to obtain low prices for generic …

Sweden has experienced a national value-based pricing (VBP) system for innovative outpatient drugs operated by the … character of a monopoly system, leading to reimbursement decisions where usage of new medicines is limited to subgroups and not … system. The aim of this article is to suggest a modification to the current reimbursement system in Sweden where payment for …

costly orphan drugs because access depends primarily on co-payments, reimbursement policies and prices. The objective of this … markets: Australia, Canada, England, France, Germany, Hungary, the Netherlands, Poland, Slovakia, Switzerland and the US …

introduction of reference pricing (RP) policies in Organisation for Economic Co-operation and Development (OECD) countries. We …